Jim Cramer Backs Eli Lilly (LLY): Will Its Drug Pipeline Dominate Pharma? An array of pharmaceutical pills with the company's logo on the bottle.

We believe there is minimal cause for concern with LLY stock, which makes it attractive but highly sensitive to adverse ...

Jim Cramer Backs Eli Lilly (LLY): Will Its Drug Pipeline Dominate Pharma? An array of pharmaceutical pills with the company's logo on the bottle. Eli Lilly and Company (NYSE:LLY) is a developer ...

The company is doubling plans for capital spending on U.S. factories as President Donald Trump pressures the pharma industry ...

Eli Lilly is expanding the supply and cutting the costs of its weight-loss drug Zepbound, broadening access to more patients ...